Nasdaq

Conformis iTotal® CR Knee Replacement System Awarded "7A" Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel

Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
Business Insider

90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements

BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of ...
Becker's ASC

3 things to know about the Cleveland surgeon using ConforMIS 3D implant tech for TKRs

Matthew Levy, MD, an orthopedic surgeon practicing at Cleveland-based St. Vincent Charity Medical Center, is bringing customized knee implant surgery using iTotal technology from ConforMIS, Cleveland ...
CNN

Conformis Announces 510(k) Clearance for iTotal® Identity PS

BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal ® ...
Becker's ASC

ConforMIS Expands Series E Financing, Plans to Use Money for iTotal Knee System

ConforMIS expanded its Series E financing to $167.7 million, according to a News-Medical report. Participants include government investment funds, private equity funds and sovereign wealth funds in ...